Engelbrecht AM - Search Results

1

Metabolic hijacking: A survival strategy cancer cells exploit?

Mitchell MI, Engelbrecht AM. Mitchell MI, et al. Among authors: engelbrecht am. Crit Rev Oncol Hematol. 2017 Jan;109:1-8. doi: 10.1016/j.critrevonc.2016.11.010. Epub 2016 Nov 21. Crit Rev Oncol Hematol. 2017. PMID: 28010894 Review.

2

Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model.

Engelbrecht AM, Toit-Kohn JL, Ellis B, Thomas M, Nell T, Smith R. Engelbrecht AM, et al. Apoptosis. 2008 Nov;13(11):1368-77. doi: 10.1007/s10495-008-0260-3. Apoptosis. 2008. PMID: 18785011

3

Circadian Rhythms and Breast Cancer: The Role of Per2 in Doxorubicin-Induced Cell Death.

Mitchell MI, Engelbrecht AM. Mitchell MI, et al. Among authors: engelbrecht am. J Toxicol. 2015;2015:392360. doi: 10.1155/2015/392360. Epub 2015 Aug 11. J Toxicol. 2015. PMID: 26347774 Free PMC article.

4

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance.

Leisching G, Loos B, Botha M, Engelbrecht AM. Leisching G, et al. Among authors: engelbrecht am. J Transl Med. 2015 Oct 16;13:328. doi: 10.1186/s12967-015-0689-4. J Transl Med. 2015. PMID: 26474854 Free PMC article.

5

Cancer stem cells: A product of clonal evolution?

van Niekerk G, Davids LM, Hattingh SM, Engelbrecht AM. van Niekerk G, et al. Among authors: engelbrecht am. Int J Cancer. 2017 Mar 1;140(5):993-999. doi: 10.1002/ijc.30448. Epub 2016 Oct 12. Int J Cancer. 2017. PMID: 27676693 Review.

6

Bone resorption: supporting immunometabolism.

van Niekerk G, Mitchell M, Engelbrecht AM. van Niekerk G, et al. Among authors: engelbrecht am. Biol Lett. 2018 Feb;14(2):20170783. doi: 10.1098/rsbl.2017.0783. Biol Lett. 2018. PMID: 29491030 Free PMC article. Review.

7

The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells.

Fourie C, Davis T, Kriel J, Engelbrecht AM. Fourie C, et al. Among authors: engelbrecht am. Exp Cell Res. 2019 Aug 15;381(2):280-287. doi: 10.1016/j.yexcr.2019.05.020. Epub 2019 May 20. Exp Cell Res. 2019. PMID: 31121155

8

Serum amyloid A and inflammasome activation: A link to breast cancer progression?

Fourie C, Shridas P, Davis T, de Villiers WJS, Engelbrecht AM. Fourie C, et al. Among authors: engelbrecht am. Cytokine Growth Factor Rev. 2021 Jun;59:62-70. doi: 10.1016/j.cytogfr.2020.10.006. Epub 2020 Oct 27. Cytokine Growth Factor Rev. 2021. PMID: 33144050 Review.

9

The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells.

Mentoor I, Engelbrecht AM, van de Vyver M, van Jaarsveld PJ, Nell T. Mentoor I, et al. Among authors: engelbrecht am. Adipocyte. 2021 Dec;10(1):505-523. doi: 10.1080/21623945.2021.1979758. Adipocyte. 2021. PMID: 34812105 Free PMC article.

10

The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.

Fourie C, du Plessis M, Mills J, Engelbrecht AM. Fourie C, et al. Among authors: engelbrecht am. Exp Cell Res. 2022 Oct 15;419(2):113334. doi: 10.1016/j.yexcr.2022.113334. Epub 2022 Aug 28. Exp Cell Res. 2022. PMID: 36044939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page